“We’re shipping four million literally as we speak. We committed to doing 100 million by June of this year,” CEO Alex Gorsky said as the first shipments rolled out.
The Johnson & Johnson vaccine is the third approved for emergency use in the United States and offers a lifeline for those waiting in line for a shot at eventually getting back to normal.
In clinical trials, the Johnson & Johnson vaccine demonstrated a 72-percent efficacy in the United States and was 100-percent effective at preventing COVID-related hospitalizations and deaths.
The vaccine can also be stored at regular refrigeration levels and requires just one shot.
The rollout comes as a growing number of communities begin to rollback COVID-19 restrictions and safety initiatives, a move that concerns doctors.
“At this level of cases, with variants spreading, we stand to completely lose the hard-earned ground we have gained,” Centers for Disease Control Director Dr. Rochelle Walensky warns.
There has been a slight uptick over the last few days in the number of new infections and deaths from the virus.
Read more: http://nbcnews.to/3dZQAC7
© 2024 KOBI-TV NBC5. All rights reserved unless otherwise stated.